Silicon Laboratories (NASDAQ:SLAB – Get Free Report) updated its first quarter 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of -0.190-0.010 for the period, compared to the consensus earnings per share estimate of -0.080. The company issued revenue guidance of $170.0 million-$185.0 million, compared to the consensus revenue estimate of $175.6 million.
Analysts Set New Price Targets
Several analysts have recently issued reports on SLAB shares. JPMorgan Chase & Co. dropped their target price on shares of Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 5th. Susquehanna initiated coverage on Silicon Laboratories in a research report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price target for the company. Morgan Stanley decreased their price objective on Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. Barclays upped their price objective on shares of Silicon Laboratories from $75.00 to $120.00 and gave the company an “equal weight” rating in a research note on Friday, January 17th. Finally, KeyCorp boosted their target price on Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a report on Wednesday, January 22nd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Silicon Laboratories presently has a consensus rating of “Hold” and a consensus price target of $133.56.
Check Out Our Latest Analysis on SLAB
Silicon Laboratories Stock Performance
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last announced its earnings results on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.07. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The company had revenue of $166.00 million during the quarter, compared to analyst estimates of $165.50 million. During the same quarter last year, the firm posted $0.48 earnings per share. Silicon Laboratories’s revenue was down 18.5% compared to the same quarter last year. On average, sell-side analysts expect that Silicon Laboratories will post -3.56 earnings per share for the current fiscal year.
Insider Buying and Selling at Silicon Laboratories
In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total transaction of $281,540.00. Following the transaction, the director now owns 32,115 shares of the company’s stock, valued at approximately $4,520,828.55. This trade represents a 5.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.72% of the stock is owned by corporate insiders.
About Silicon Laboratories
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Further Reading
- Five stocks we like better than Silicon Laboratories
- How to Start Investing in Real Estate
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- There Are Different Types of Stock To Invest In
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
- Top Biotech Stocks: Exploring Innovation Opportunities
- High-Yield Dividend King PepsiCo Offers Value Too Good to Ignore
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.